Clinical trials
2 active studies led by ATI Holdings, LLC, of 2 in all
Source: ClinicalTrials.gov, Studies with ATI Holdings, LLC (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 1Markets in public records
- 0Regions & countries
- 2Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by ATI Holdings, LLC or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on ATI Holdings, LLC
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Company facts
- Stock listing
- NYSE: ATI
- Type
- Other
Source: SEC EDGAR, Company filings, CIK 1018963. Retrieved 13 Nov 2026.
See them on ClinicalTrials.gov (opens in a new tab)
SEC filings
Annual reports and other filings with the US Securities and Exchange Commission.
Source: SEC EDGAR, Company filings, CIK 1018963.
Markets where public records show them
Markets we cover where free public records show ATI Holdings, LLC: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets ATI Holdings, LLC is in.
From our blog
Stories on the topics ATI Holdings, LLC works in.
Health Data Exchange: Why EDI Matters for Payers and Providers
Behind every insurance claim is a standard electronic message. The CAQH Index says $20 billion a year could…
Read
Wound Care: Advanced Dressings for Faster Healing
Nearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year…
Read
Bioinformatics: Making Sense of Health Data
Sequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
Read